Premium Thymosin Alpha 1 (Thymalfasin) for Sale | 5mg Lyophilized Powder | ≥98% Purity | 48-Hour Delivery Across EU & UK

Thymosin Alpha 1: The Master Immunomodulatory Peptide for Advanced Research

eupeptidelap.co.uk is proud to present Thymosin Alpha 1 (Tα1) 5mg, a premium research-grade synthetic peptide identical to the endogenous human immunomodulator, manufactured to the highest analytical standards. As a trusted peptide vendor uk and leading EU peptide supplier, we provide researchers across Europe with Thymosin Alpha 1 for sale that delivers exceptional purity, consistency, and documented quality for advanced studies in immunology, aging, and infectious disease research .

Thymosin Alpha 1 is a 28-amino acid peptide (N-acetyl-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Glu-Glu-Glu-Ala-Glu-Asn) with a molecular weight of 3108 Da . First isolated from thymic tissue in the 1960s, it was identified as the compound responsible for restoring immune function in thymectomized mice and has since become one of the most extensively studied immunomodulatory peptides in scientific literature . It is chemically synthesized to be identical to the native human peptide and is also known internationally as Thymalfasin .

The peptide exerts a pleiotropic mechanism of action, affecting multiple immune cell subsets involved in immune regulation . It acts as an agonist for Toll-like receptors (TLRs), specifically TLR2 and TLR9, on antigen-presenting cells such as myeloid and plasmacytoid dendritic cells . This activation initiates signaling pathways that stimulate the production of immune-related cytokines and drive a T-helper 1 (Th1) polarized immune response, characterized by the production of key cytokines like interferon-gamma (IFN-γ) and interleukin-2 (IL-2) .

For researchers seeking to buy peptide online EU for investigations into immune modulation, vaccine enhancement, cancer immunotherapy, or the mechanisms of aging and immunosenescence, eupeptidelap.co.uk offers this premium research compound with comprehensive documentation, including Certificates of Analysis and batch-specific purity data. Whether your laboratory is based in London, Berlin, Paris, or anywhere in the European Union, our guaranteed 48 hour delivery peptide service ensures your research continues without interruption.

The Scientific Foundation of Thymosin Alpha 1 Research

Discovery and Historical Context

Thymosin Alpha 1 was first isolated as a biologically active component of “thymosin fraction 5,” a crude extract derived from bovine thymus tissue that contained a mixture of immunologically active peptides . Its initial identification was rooted in its ability to restore immune function in animal models where the thymus had been removed . The subsequent isolation and characterization of Tα1 as a distinct, 28-amino acid polypeptide allowed for its precise chemical synthesis, leading to the development of a compound identical in sequence to the native human peptide . Endogenous Tα1 serum levels in healthy adults are typically in the 0.1–1.0 ng/mL range, though concentrations can be lower in diseased individuals .

Molecular Mechanism: Toll-like Receptor Activation

The primary mechanism of Thymosin Alpha 1 involves its action as a Toll-like receptor (TLR) agonist. It has been shown to activate TLR9 and TLR2 on both myeloid and plasmacytoid dendritic cells . This engagement triggers intracellular signaling pathways that lead to dendritic cell activation and maturation. Consequently, this stimulates the production of cytokines that promote a Th1-type immune response, enhancing the body’s cellular immunity against pathogens and tumors . This pathway is central to its ability to restore function in immune-compromised states.

Immune Reconstitution and Cell Signaling

In keeping with its original identification as a compound responsible for reconstituting immune function, Tα1 influences several intracellular cell-signaling pathways associated with immune stimulation . It has been shown to enhance the differentiation of T-cells, improve the function of natural killer (NK) cells, and modulate the activity of macrophages . This broad activity makes it a powerful tool for studying the complex network of immune regulation.

Key Research Applications

Immunology and T-Cell Development Research

Thymosin Alpha 1 is extensively used in studies investigating immune system function, T-lymphocyte maturation, and cellular immunity. It has been shown to stimulate the differentiation and maturation of T-cells, increase the expression of interleukin-2 (IL-2) receptors on lymphocytes, and enhance the production of key cytokines . In preclinical models, it helped restore immune responses in aged or immunosuppressed animals .

Aging and Immunosenescence Research

A landmark review published in the International Journal of Molecular Sciences (November 2025) highlighted the critical role of Thymosin Alpha 1 in combating age-related immune decline . The thymus gland loses up to 95% of its immature immune cells with age, a process known as thymic involution, which is a primary driver of immune aging . Tα1 directly counteracts this decline by:

Stimulating the Thymus: It increases expression of interleukin-7 (IL-7), a growth signal critical for T-cell survival, enhances the conversion of stem cells into new T-cells, and prevents premature immune cell death .
Enhancing Bone Marrow Output: Tα1 has been found to boost immune cell production at the source where all blood cells originate .
Reprogramming the Inflammatory Set Point: Aging immune systems shift toward constant low-grade inflammation (“inflammaging”). Tα1 reprograms dendritic cells to increase anti-inflammatory output (IL-10) while dialing down suppressive molecules . In macrophages, it reduces production of major inflammatory drivers TNF-α, IL-1β, and IL-6 by suppressing the NF-κB pathway .

Vaccine Enhancement Research

Due to its potent immune-stimulating effects, Tα1 is a powerful candidate for research into vaccine efficacy, particularly in immunocompromised populations or the elderly who typically show poor vaccine responses . By boosting T-cell mediated immunity, it can potentially enhance the body’s ability to mount a protective response following vaccination.

Infectious Disease Research

Thymosin Alpha 1 has been extensively studied in the context of both acute and chronic infections, including viral (such as chronic hepatitis B and C), bacterial, and fungal infections . Its ability to restore immune function makes it a valuable tool for investigating host-pathogen interactions and immune deficiencies caused by severe infections like sepsis .

Cancer and Immuno-Oncology Research

The peptide’s immunostimulatory activity has led to its application in diverse pathological conditions, including cancer. Early clinical trials assessed its efficacy in patients with primary immunodeficiencies and cancer . Research has shown promising results in different types of malignancies, especially when Tα1 was used in combination with other chemo- and immune therapies . Its role is being revisited in the context of modern immune checkpoint inhibitors, where it could potentially “turn a cold tumor into a hot one” and reduce adverse effects .

Neuroprotection and Cognitive Research

Tα1 has demonstrated neuroprotective properties. In a clinical study of patients with immune deficiency complicated by major depressive disorder, Tα1 administration stabilized immune markers and reduced depressive symptoms . Preclinical evidence shows it can stimulate new neuron growth, improve cognitive function, and restore nerve growth factor levels in the brain . It also modulates synaptic transmission in the hippocampus, the brain region most critical for memory .

Antioxidant and Cardiovascular Research

As a direct antioxidant, Tα1 has been shown to reduce reactive oxygen species (ROS) in various cell types and neutralize hydrogen peroxide and superoxide radicals . It also inhibits angiotensin-converting enzyme (ACE), suggesting a potential role in regulating blood pressure through the same pathway as ACE-inhibitor medications . Furthermore, Tα1 can protect cells from oxidative damage, which has implications for research into atherosclerosis and other oxidative stress-related diseases .

Quality Assurance: Setting the Standard for Research Compounds

Manufacturing Excellence

eupeptidelap.co.uk sources Thymosin Alpha 1 5mg from certified GMP facilities with rigorous quality control protocols:

HPLC Purity Analysis: ≥98% purity verified by high-performance liquid chromatography
Mass Spectrometry Verification: Molecular weight confirmation (3108 Da) via LC-HRMS
Batch-Specific Certificates of Analysis: Complete documentation for each production run
Third-Party Lab Testing: Independent verification of purity and potency
Research-Use Only (RUO) Labeling: Full compliance with research compound regulations

Chemical and Product Specifications

Specification	Detail
Product Name	Thymosin Alpha 1 (Thymalfasin, Tα1)
CAS Number	62304-98-7 / 69440-99-9
Molecular Formula	C₁₂₉H₂₁₅N₃₃O₅₅
Molecular Weight	3108.28 Da
Amino Acid Sequence	N-acetyl-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Glu-Glu-Glu-Ala-Glu-Asn
Purity	≥98% (HPLC verified)
Appearance	White lyophilized powder
Form	Lyophilized powder
Solubility	Soluble in water (0.3 mg/mL)
Storage (Lyophilized)	2-8°C; protect from light and moisture
Storage (Reconstituted)	-20°C; use within short-term; avoid repeated freeze-thaw
Shipping	Ambient temperature with protective packaging
Intended Use	Research and laboratory use only
Documentation	Certificate of Analysis provided with each batch

Stability and Handling Guidelines

Lyophilized Powder Storage: Store Thymosin Alpha 1 lyophilized powder at 2–8°C in a dry, dark environment, protected from light and moisture . Under proper storage conditions, the powder maintains stability for up to 3 years .

Reconstitution Protocol:

Allow vial and solvent to reach ambient temperature before opening to prevent condensation
Reconstitute using sterile water, bacteriostatic water, or appropriate buffer according to research protocol (water solubility ~0.3 mg/mL)
Inject solvent slowly down the inside wall of the vial to minimize foaming
Gently swirl or roll the vial until fully dissolved—do not shake vigorously
Label the vial with the date of reconstitution
For storage, aliquot and store at -20°C

Reconstituted Solution Storage: Once reconstituted, it is recommended to aliquot into single-use portions and store at -20°C, protected from light and moisture . Avoid repeated freeze-thaw cycles.

Protection from Light and Moisture:

Store in original packaging protected from light
Keep vials tightly sealed when not in use
Allow refrigerated vials to reach room temperature before opening to prevent condensation

Key Benefits

Premium Quality Manufacturing: GMP-certified production, ≥98% HPLC-verified purity
Clinically Validated Peptide: Extensively studied in over 11,000 patients; approved in 35+ countries
Pleiotropic Immunomodulator: Affects multiple immune cell subsets including T-cells, dendritic cells, macrophages, and NK cells
TLR Agonist: Acts through TLR2 and TLR9 to initiate immune signaling cascades
Aging Research: Directly counteracts thymic involution and immunosenescence
T-Cell Development: Stimulates T-cell differentiation and maturation, enhancing thymic output
Cytokine Modulation: Drives Th1 immune response (IFN-γ, IL-2) and reduces pro-inflammatory cytokines (TNF-α, IL-1β, IL-6)
Vaccine Enhancement Research: Boosts immune responses in immunocompromised populations
Infectious Disease Studies: Proven efficacy in models of viral, bacterial, and fungal infections
Cancer Immunotherapy Research: Enhances activity of checkpoint inhibitors and combination therapies
Neuroprotection: Promotes neurogenesis, improves cognitive function, and reduces depressive symptoms
Antioxidant Properties: Reduces ROS and neutralizes free radicals; protects against oxidative stress
Cardiovascular Research: Inhibits ACE, suggesting potential for blood pressure regulation studies
NF-κB Pathway Modulation: Suppresses inflammatory NF-κB while increasing antioxidant Nrf-2
Regulatory T-Cell (Treg) Activation: Activates Tregs to suppress autoimmunity
High Conservation: Amino acid sequence is homologous across bovine, porcine, ovine, and human species
Comprehensive Documentation: Certificates of Analysis with batch-specific purity data
48-Hour EU & UK Delivery: Rapid shipping to research facilities across Europe
Batch Consistency: Rigorous quality control ensures lot-to-lot reproducibility
EU Sourced: Available from within the European Union

Frequently Asked Questions

Q: What is Thymosin Alpha 1?

A: Thymosin Alpha 1 (Tα1, Thymalfasin) is a 28-amino acid synthetic peptide identical to the endogenous human immunomodulatory peptide first isolated from thymic tissue . It plays a critical role in regulating immune function by stimulating T-cell differentiation, modulating cytokine production, and activating key immune cells .

Q: What is the molecular weight and sequence of Thymosin Alpha 1?

A: Thymosin Alpha 1 has a molecular weight of 3108.28 Da and the amino acid sequence: N-acetyl-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Glu-Glu-Glu-Ala-Glu-Asn .

Q: What purity level can I expect when I buy Thymosin Alpha 1 from eupeptidelap.co.uk?

A: All Thymosin Alpha 1 from eupeptidelap.co.uk is tested to ≥98% purity by HPLC. Each batch is individually analyzed, and Certificates of Analysis are provided with every order, ensuring you receive material suitable for rigorous research applications.

Q: What is the mechanism of action of Thymosin Alpha 1?

A: Thymosin Alpha 1 acts as an agonist for Toll-like receptors (TLR2 and TLR9) on dendritic cells, leading to their activation . This triggers a signaling cascade that stimulates the production of Th1-type cytokines (such as IFN-γ and IL-2), enhances T-cell differentiation, modulates macrophage activity, and can suppress key inflammatory pathways like NF-κB .

Q: What research areas commonly use Thymosin Alpha 1?

A: Tα1 is widely used in immunology research (T-cell development, immune modulation), aging and immunosenescence studies , infectious disease research (viral, bacterial, fungal) , vaccine enhancement studies , cancer immunotherapy research , neuroprotection and cognitive research , and antioxidant/cardiovascular research .

Q: How does Thymosin Alpha 1 relate to aging research?

A: The thymus gland shrinks with age (thymic involution), leading to immune decline. Tα1 has been shown to counteract this by stimulating new T-cell production in the thymus and bone marrow, reducing inflammatory cytokines (IL-6, TNF-α), and activating the antioxidant Nrf-2 pathway, thus addressing multiple facets of immunosenescence .

Q: How should I store Thymosin Alpha 1 for long-term stability?

A: Store lyophilized Thymosin Alpha 1 powder at 2-8°C, protected from light and moisture . Under proper storage conditions, the powder maintains stability for up to 3 years . After reconstitution, aliquot into single-use portions and store at -20°C. Avoid repeated freeze-thaw cycles.

Q: What is the solubility of Thymosin Alpha 1?

A: Thymosin Alpha 1 is soluble in water at approximately 0.3 mg/mL . Reconstitute using sterile water or appropriate buffer according to your research protocol.

Q: Do you ship Thymosin Alpha 1 to EU countries?

A: Yes. As a dedicated EU peptide supplier, we ship Thymosin Alpha 1 to all European Union member states with our guaranteed 48 hour delivery peptide service. Our EU fulfilment centre ensures rapid delivery without customs delays.

Q: What documentation do you provide with Thymosin Alpha 1 orders?

A: Every order includes a Certificate of Analysis (COA) with batch-specific purity data. Additional documentation, including HPLC chromatograms and mass spectrometry data, is available upon request for researchers requiring comprehensive analytical verification.

Q: Has Thymosin Alpha 1 been studied in clinical trials?

A: Yes. Thymosin Alpha 1 (as Thymalfasin) has been extensively studied in clinical trials, with over 4,400 subjects enrolled in US, European, and Chinese studies . It is approved as a drug for the treatment of chronic hepatitis B and C in over 35 countries, though it remains unapproved by the FDA and EMA, where it holds orphan drug status for hepatocellular carcinoma .

Q: Does Thymosin Alpha 1 have antioxidant properties?

A: Yes. Research shows Tα1 reduces reactive oxygen species (ROS) in macrophages, thymocytes, and brain astrocytes; neutralizes hydrogen peroxide; increases the body’s own antioxidant enzyme activity; and activates the master antioxidant switch Nrf-2 .

Q: Do you offer bulk quantities of Thymosin Alpha 1 for institutional research?

A: Yes. We accommodate bulk orders for research institutions. Contact our team at sales@eupeptidelap.co.uk for volume pricing, custom requirements, and supply agreements for ongoing research programs.

Advance Your Research with Thymosin Alpha 1 5mg

eupeptidelap.co.uk is your trusted source for Thymosin Alpha 1 5mg, the premium choice for researchers investigating immune modulation, aging, infectious diseases, and cancer immunotherapy. With over four decades of preclinical and clinical research supporting its pleiotropic immunomodulatory effects, Thymosin Alpha 1 represents one of the most extensively studied and versatile peptides in the research community . ...........................................

Whether you are exploring T-cell development pathways, designing immunosenescence studies, investigating vaccine enhancement, or researching novel cancer immunotherapies, our rigorously tested compound provides the quality and consistency your work demands. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Order today and experience the eupeptidelap.co.uk difference – premium quality, rapid 48-hour delivery across the EU and UK, and expert support for the European research community.

Thymosin Alpha 1 Denmark

Thymosin Alpha 1 5mg